Delivery Order SPE2DB22D3016-SPE2DB25FBJL5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,193.99 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectors, with an ultimate completion date of August 12, 2025. This competitive award was issued on August 11, 2025, under a firm fixed price contract type with no set-aside designation. The performance location is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a $10,843.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injections on June 20, 2025, with a completion date of June 23, 2025. This non-set-aside contract represents a routine pharmaceutical supply order fulfilling military healthcare needs through the federal medical procurement system. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,073.50 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injections (0.5 mL units). This is a firm fixed price delivery order with an ultimate completion date of September 15, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $13,618.11 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors on September 12, 2025, with a completion date of September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $111,508.90 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on September 5, 2025, with completion expected by September 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract covers pharmaceutical supply for federal medical...
- The Defense Logistics Agency awarded a $1,360.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injection medication. The delivery order, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a non-competitive award under the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.19 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen injections on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections. This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $9,795.24 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen units on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply to support federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJL5Delivery Order
The Defense Logistics Agency (DLA) awarded a $8,444.80 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectables, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 9/15/25 |